NCT04626713 is a NA clinical trial of Brain-Computer Interface in Anxiety, sponsored by Duke-NUS Graduate Medical School.

Who is sponsoring NCT04626713?

NCT04626713 is sponsored by Duke-NUS Graduate Medical School.

What drugs are being tested in NCT04626713?

Interventions in NCT04626713: Brain-Computer Interface.

Is NCT04626713 still recruiting?

NCT04626713 is currently status unknown. Last updated 17 November 2021.

Last reviewed 2021-11-17 · How we verify

NCT04626713

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Online Home-based Intervention for Anxiety Regulation

Status unknown NA Last updated 17 November 2021

What this trial tests

NA trial testing Brain-Computer Interface in Anxiety in 30 participants. Status unknown.

Timeline

5 January 2021

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Duke-NUS Graduate Medical School
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	5 January 2021
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across Singapore

Drugs / interventions tested

Brain-Computer Interface

Conditions studied

Anxiety — all drugs for Anxiety →

Sponsor

Duke-NUS Graduate Medical School

Who can join

Adults 21 to 35, any sex, with Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this project is to evaluate the safety and acceptability of our online, home-based, personalized, neuro-technological mindfulness-based intervention in entraining anxiety regulation and ameliorating anxiety in healthy adults. Our technology will deliver a mindfulness-based anxiety regulation intervention through a neuro-/ bio-feedback-based game interface that is driven by an electroencephalography (EEG) algorithm. We hypothesize that the intervention would be safe and acceptable. In exploratory analyses, we further hypothesize that the intervention would help entrain anxiety regulation and ameliorate anxiety in healthy adults. Data will be analyzed quantitatively and qualitatively to inform development of our intervention and future research studies.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Personalized Brain-Computer Interface-based Intervention for Mindful Anxiety Regulation in Young Adults: A Randomized Clinical Trial
Tan WJ, Ding Y, Lin XB, Robinson N, et al · · 2024 · DOI 10.1101/2024.03.01.24303187

Verify or expand the search:

Other trials of Brain-Computer Interface

Trials testing the same drug.

NCT04724824 — Validation of a Brain-Computer Interface for Stroke Neurological Upper Limb Rehabilitation · NA · completed

Other recruiting trials for Anxiety

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting

Other Duke-NUS Graduate Medical School trials

Trials by the same sponsor.

NCT07309367 — Web-based Advance Care Planning Intervention for Patients With Kidney Failure on Dialysis: Pilot Testing of 'My Voice' · NA · recruiting
NCT06817876 — Connecting Caregivers With Community Services: The Care Buddy Platform · NA · recruiting
NCT06440421 — Understanding Food Choices in Bahrain Using Bahrain e-Mart · NA · completed
NCT06102954 — A Multi-domain and Multi-component Falls Intervention Program for Community- Dwelling Older Adults: SAFE-TECH · NA · recruiting
NCT06155981 — Coca-Cola Zero (®) Consumption on Night-call Inpatient Course and Mortality · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04626713 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke-NUS Graduate Medical School
Last refreshed: 17 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04626713.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing